Impamyabumenyi

Uburyo bushya bwo kwerekana imivura ya kanseri hamwe nicyuma cyamazi & kuvura immuno: birashobora gushika kubagwa benshi, imiti ya chimiotherapie kubibyimba byose byabyibushye

Ibiyobyabwenge bivanze na H2 O2 Gutera Interandol kugirango uhindure matrix idasanzwe

Ibyiringiro bishya byo kuvura kanseri hamwe nicyuma cyamazi & kuvura impindu: umipic

Ikirenge gikaze hamwe na CD4 / 8 + na CD11

Gutwika gukabije hamwe no kwerekana ibintu byihariye bya CD11 & CD4 bitanga ingaruka zibyibushye mu gutera inshinge za chemitherapy ibiyobyabwenge hamwe na moderi

Igihe gishya cyo kubaga LMMUNO kiraza: Uburyo bwo gushushanya umurongo bwo guhagarika guhagarika izina ryamazi & lmmmuno therapy

Ikirenge gikaze hamwe na CD4 / 8 + na CD11 + Kuringaniza ingaruka zo kubaho zatewe no gutera intoki neza guhuza ibiyobyabwenge bya chimiotherapy hamwe na moderi yinyamanswa

Kanguka Ingirabuzimafatizo za Hapten Yongereye Chemotherapi ya Chemotheraping Nanicillin Prolong Kanseri ya Pencreatique

Kwitegura kwibasi muri Oncogenic Necleanic Antigen by Hapten yateye ikibyimba bifitanye isano na Autoantibodiboli (Itaa)

Impuhwe ziterwa na Inteter Hapten wongeyeho imiti ya chemotherapy ya endometrialcancer

Kanseri Gutegura Imyumbati Yumupfumu no Gukora Akagari ka Milling binyuze muri Chimotherapi-yazamutse muri kanseri yibanze

Guhuza ubudahangarwa bwa chimique guhuza ibihugu byurubanza byubahwa gukangura ibihangano bidahumahanga kandi bigarura ibiro bisanzwe bya HPV nibisanzwe kandi bidasanzwe

Ingaruka za Sodium Stibogluconate mu gushaka no gukangura ingirabuzimafatizo z'umudahangarwa mu mazi meza ya kanseri yuzuye ya Pancreatic: Gutegura Imyumuburo

Koresha umwirondoro wa SCRNA-SEQ kugirango usobanure umupfumu nyuma yinjira muri winor Hapen kuzamura chimiotherapie ku rubanza rwa anaclaricttoma Umwijima wa MeMandioperictytoma: Raporo y'urubanza

Gukora imiti mibi ya chimique ifite ubumuga bwo kudahariza ibiyobyabwenge muri kanseri y'inkondo y'umura idafite hysterectomy: kubyuka ingirabuzimafatizo z'umudatumira impfubyi

Ubuvumbuzi bwa Biomarker muri Carcinoma ya Hepatocellilamu (HCC) kubikorwa byihariye no kuzamura prognose

Impamyabumenyi

Nyamuneka tudusige ubutumwa